Objective: To study the compliance and changes in plasma lipids, plant sterols, fat-soluble vitamins and carotenoids in children and parents with familial hypercholesterolemia (FH) consuming a plant sterol ester-enriched (PSE) spread. Design: A 26-week open-label follow-up of children who had previously been studied in a controlled cross-over design. The parents were also included in the open-label arm of the study. Setting: Outpatient clinic for treatment of hyperlipidemia. Subjects: A total of 37 children (7-13 y) and 20 parents (32-51 y) diagnosed with 'definite' or 'possible' heterozygous FH. In all, 19 of the parents, but no children, used statins. All were patients at the Lipid Clinic, National Hospital in Oslo. Interventions: Subjects were recommended to eat 20 g/day of PSE spread as part of their lipid-lowering diet. Results: The mean intake of PSE spread was 13.7 and 16.5 g/days in the children and parents, respectively, corresponding to 1.2 and 1.5 g of plant sterols. Plasma total cholesterol decreased by 9.1% in both children (Po0.001) and parents (P ¼ 0.002). The corresponding decreases in LDL cholesterol were 11.4% (Po0.001) and 11.0% (P ¼ 0.012). Increases in serum lathosterol, campesterol and sitosterol, adjusted for total cholesterol, were observed in the children (31, 96, 48%, respectively, Po0.001) at the end of the controlled cross-over period. In the parents, serum campesterol and sitosterol, adjusted for total cholesterol, increased by 92 and 39%, respectively (Po 0.001). Lipid-adjusted serum a-and b-carotene decreased by 17.4% (P ¼ 0.008) and 10.9% (P ¼ 0.018), respectively, in the children at the end of the controlled PSE period, but increased again during the followup. In the parents, serum a-and b-carotene concentrations were unchanged, while serum lutein and lycopene decreased by 7.3% (P ¼ 0.037) and 14.6% (P ¼ 0.044), respectively. Conclusions: Sustained efficacy of cholesterol reduction and long-term compliance of PSE intake were demonstrated in this study.
Introduction
Familial hypercholesterolemia (FH) is the most commonly recognized disorder of lipoprotein metabolism in childhood with an incidence of 1 in 200-500 individuals (Goldstein et al, 1995) . Subjects with heterozygote FH have only 50% of the LDL receptors of normal healthy people. Thus, children with FH are born with a higher concentration of circulating cholesterol, which requires early treatment to slow down the atherosclerotic process. Statins (HMG-CoA reductase inhibitors) are now evaluated for long-term use in patients younger than 18 y old, who are at high coronary heart disease risk. Dietary changes are, however, the first approach in the treatment of FH in children. The commonly recommended dietary changes are exchanging saturated with unsaturated fats, decreasing dietary cholesterol and increasing the intake of fruit and vegetables. In addition, a supplement of phytosterols by means of plant sterol-enriched spread has been shown to be an effective way of lowering blood cholesterol levels in FH children (Amundsen et al, 2002; de Jongh et al, 2003) . In several clinical studies, the intake of spread enriched with plant sterol esters or plant stanol esters has been shown to induce a significant serum cholesterol reduction. Doses of about 1.5-3 g/day of plant sterols or stanols may reduce total cholesterol by 8-17% and LDL cholesterol by 9-19%. Gylling et al, 1995 Gylling et al, , 1997 Weststrate & Meijer 1998; Hallikainen & Uusitupa 1999; Hendriks et al, 1999 Hendriks et al, , 2003 Moghadasian & Frohlich 1999; Hallikainen et al, 2000a; Law, 2000; Jones et al, 2000; Nestel et al, 2001; Geelen et al, 2002 ). An intake of 20-25 g of spread per day is necessary to get about 2 g of plant sterols, which is considered an optimal dose for lowering blood total and LDL cholesterol (Hendriks et al, 1999; Law, 2000) . In all , 2 g of plant sterols or stanols per day is now also recommended by the National Cholesterol Eduaction Program (NCEP) ATP III guidelines as part of a lipid-lowering diet (Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult treatment panel III, 2001 ).
In a recent study at the Lipid Clinic, National Hospital in Norway, we found a high (91%) compliance to PSE-enriched spread consumption in FH children aged 7-13 y old in a controlled 2 Â 8 weeks cross-over study (Amundsen et al, 2002) . In the present study, we have pursued the same children and their parents with FH during a 6-month followup intervention after the controlled period in an open-label trial. The aims were to look at any sustained long-term effect of plasma lipids and level of compliance following an uncontrolled free intake of plant sterol ester-enriched (PSE) spread. In addition, a secondary objective was to measure changes in serum concentrations of non-cholesterol sterols, fat-soluble vitamins and carotenoids in children and their parents during the extended open-label period. Some unpublished results from the preceding cross-over study are also presented here.
Subjects and methods

Subjects
In total, 41 healthy children were recruited from the patient register at The Lipid Clinic at the National Hospital in Oslo. All subjects were diagnosed with 'definite' or 'possible' heterozygous FH (Ose, 1999) . The diagnosis was documented by the presence of an FH mutation in 25 of the children. In the other 16 subjects, the responsible mutation was still unidentified. All children were healthy and none had clinical symptoms of hypercholesterolemia or used serum cholesterol-lowering drugs. Four subjects used drugs against allergy or asthmatic problems. A total of 13 children took fish oil supplements (cod-liver oil or omega-3 supplements) and eight children took multivitamin supplements during the study. The cod-liver oil was usually taken in doses of 5 ml/ day, but some of the children did not take the supplement daily. At the time of the study, 5 ml of cod-liver oil (Møllers tran s , Peter Møller AS, Norway) contained 500 mg retinol, 10 mg a-tocopherol and 10 mg vitamin D. Several different multi-vitamin supplements were used and these contained about 300-800 mg retinol, 5 mg a-tocopherol and 5 mg vitamin D. None of the supplements contained carotenoids. The subjects were instructed to take the same doses of medication and supplements during the whole study period. In all, 38 of the 41 children completed the controlled crossover study and 37 of them completed the open-label followup period.
A total of 22 parents volunteered to participate in the open-label follow-up period. All except one used hypocholesterolemic drugs (statins). Four of the subjects had a history of coronary heart disease, but were otherwise healthy. Three subjects used thyroxin. In 17 of the parents, FH was confirmed by genetic tests, while the responsible mutations were not identified in the other five subjects. Two subjects were excluded from the result analyses, one because the dose of hypocholesterolemic medication had changed in the middle of the study, and the second person stopped taking the spread because of gastrointestinal problems not related to the spread. Clinical characteristics of the included subjects are presented in Table 1 .
Written informed consents were signed by the parents of the enrolled children, and the study was approved by the Regional Committee for Medical Research Ethics, Southern Norway.
Experimental design
The controlled cross-over study has been previously described in detail (Amundsen et al, 2002) . In summary, the study was a cross-over design, 2 Â 8 weeks, where children were instructed to eat 20 g of either a PSE or control spread. Blood samples were taken at the start and end of each intervention period. The first intervention period lasted from October to December and the second from January to March with half of the group starting with PSE and the other half with control spread (Figure 1) . The present open-label follow-up study started immediately after the end of the cross-over and lasted from March to September (26 weeks) for all subjects. During the open-label study, 37 children and Table 2 . Plant sterols were extracted from soybean and other vegetable oils such as sunflower oil and esterified with fatty acids from sunflower seed oil to an esterification degree of 85-90%. The PSE spread contained 8.8% of free plant sterols, of which about 50% was sitosterol. In all, 20 g of the spread supplied 1.76 g of plant sterols, mainly as sitosterol ester.
Check of compliance
The tubes for the children and parents were labelled and kept separately for measurement of individual compliance. They were instructed to empty one tub in about 2 weeks and to sample all empty tubes and left-over and return them to the clinic. During the 26-week follow-up period, the parents visited the clinic once for a compliance check and once for a new delivery of spread. The empty tubes and left-over were weighed and compliance was calculated according to the recommended intake of 20 g/day.
Analyses
Venous blood samples were obtained after a 12-h overnight fast. Serum and plasma were isolated within 30 min and stored at À701C until analyzed. Plasma total cholesterol, LDL cholesterol, HDL cholesterol, triacylglycerol (TG), apolipoprotein A-I (ApoA-I) and apolioprotein B (Apo B) were analyzed from frozen samples 1-6 months after sampling at the local laboratory at the National Hospital in Oslo. Total cholesterol, HDL cholesterol and TG were analyzed enzymatically (Boehringer Mannheim) and LDL cholesterol was calculated by Friedewalds equation (Friedewald et al, 1972) . Apo A-I and Apo B were analyzed by immunonephrometry using Behrings instrument and reagents (Dade Behringer, Marburg, Germany). Serum concentrations of carotenoids, retinol and atocopherol were analyzed from frozen serum samples at the Commonwealth Scientific and Industrial Research Council Organisation (CSIRO) in Adelaide, Australia. Serum was collected and stored in light-protected tubes at À701C for 10-12 months before analyzing. Serum extractions were performed according to the method of Yang and Lee (1987) , and carotenoids, retinol and a-tocopherol were determined by HPLC. Minor modifications to this method were derived from (Khachik et al 1992; Amundsen et al, 2002) . Serum carotenoids, retinol and a-tocopherol concentrations were standardized for plasma lipid concentration (total cholesterol and TG) because the lipoproteins are carriers of carotenoids and fat-soluble vitamins.
Serum phytosterols were determined from frozen samples at CSIRO in Adelaide, Australia, using gas chromatography based on a modification of the method previously described (Wolthers et al, 1991) . Briefly, 400 ml of serum sample was saponified with 400 ml of 33% KOH at 601C for 30 min, cooled and extracted with hexane. The extract was evaporated to dryness with a stream of nitrogen and the phytosterols were derivatized by treatment with 150 ml SyLON BTZ for 30 min at 801C. The silyl derivatives of the phytosterols were extracted with hexane, concentrated with a stream of nitrogen to 50 ml and a 1 ml aliquot was injected onto the GC column (split ratio 1:10). The gas chromatograph was a DANI 6500 instrument equipped with a split/ splitless injector, flame ionization detector coupled to a DELTA computerized chromatography data system. The injector, detector and oven temperatures were set at 275, 275 and 2801C, respectively. The capillary column used was a 60 m Â 0.22 mm BPX5 (SGE Australia). Serum phytosterol concentrations were calculated from the standard curves using the ratio of the phytosterol peak area to the peak area of the internal standard (5b-cholestan-3a-ol). The pure internal standard, lathosterol, campesterol and sitosterol reference samples were obtained from Sigma Chemicals Co (St Louis, USA). Apo E genotype was analyzed at The Medical Genetics Laboratory (National Hospital, Oslo, Norway) using the method of Eiklid & Leren (1993) .
Statistical methods
Statistical analyses were performed using SPSS for WIN-DOWS 6.0 statistics program (SPSS Inc. Chicago). Descriptive data and results are presented as means and standard deviation (s.d.). Two-sided Students t-test, paired comparisons were used to determine statistical differences between baseline and end point in both children and parents. Regression analyses were used for testing the interaction between cod-liver oil intake and lipid changes. A significance level of Po0.05 was considered to be significant.
Results
Compliance
In the preceding controlled cross-over study, the intake of PSE and control spread in children was 18.271.5 and 18.071.7 g/day, respectively, equivalent to a mean intake of plant sterols in the PSE period of 1.670.13 g/day. The intake of PSE spread in the present open-label follow-up period was 13.774.5 and 16.576.1 g/day in the children and parents, respectively, corresponding to 1.2170.40 and 1.4570.54 g of plant sterols.
Serum lipids and lipoproteins
The plasma lipid and lipoprotein concentrations in children are shown in Table 3 . Total plasma and LDL cholesterol levels were 8.3 and 10.9% lower (Po0.001), respectively, at the end of the PSE period compared to the control period in the cross-over study. At the end of the open-label period, total and LDL cholesterol were 9.1 and 11.4% lower than the control values, respectively. Plasma HDL cholesterol was 4.8% (P ¼ 0.041) lower after the follow-up period, while no changes were seen in TG and Apo A-1. Mean Apo B level was 11.5% (Po0.001) and 6.8% (P ¼ 0.001) lower in the controlled PSE and the open-label period, respectively. No interaction was found between the use of cod-liver oil and the effect of the PSE spread on serum lipids in the children (data not shown).
In the parents, total and LDL cholesterol decreased by 9.1% (P ¼ 0.002) and 11.0% (P ¼ 0.012), respectively, during the 6 months follow-up period as compared to baseline (Table 3) . HDL cholesterol decreased by 10.6% (Po0.001) and Apo B decreased by 7.2% (P ¼ 0.049), while no changes were observed in TG or Apo A-I. All liver function parameters were within the normal reference range in both children and parents (data not shown).
Non-cholesterol sterols
The changes in serum lathosterol, campesterol and sitosterol have not been presented earlier for the cross-over study, and are shown in Table 4 together with the follow-up data and the data of the parents. Due to loss of samples during transportation and storage, the serum non-cholesterol sterols were analyzed in 29 children and 15 parents only. In the PSE controlled diet period, the serum concentration of lathosterol, adjusted for total cholesterol, increased in the children by 31% (Po0.001). At the end of the open-label In the parents, the increases in serum lathosterol, campesterol and sitosterol, adjusted for total cholesterol, between the start and end of the 26 weeks of PSE intake were 5% (ns), 92% (Po0.001) and 39.1% (Po0.001), respectively. The percentage of serum campesterol and sitosterol of total sterols increased from 0.44 to 0.72% and thus remained well below 1% of total serum sterols.
Carotenoids and fat-soluble vitamins
The serum concentrations of carotenoids and fat-soluble vitamins in the children and parents are presented in Table 5 . At the end of the PSE controlled diet and open-label period, the lipid adjusted retinol concentration was 8.0% (P ¼ 0.002) and 11.8% (Po0.001), respectively, higher than in the control diet period. Serum a-tocopherol was also The lipid-adjusted serum retinol and a-tocopherol concentrations in the parents increased by 13.1% (P ¼ 0.027) and 8.3% (P ¼ 0.036), respectively. Serum concentrations of lipidadjusted lutein decreased by 7.3% (P ¼ 0.037) and lycopene by 14.6% (P ¼ 0.044). No significant changes were seen in serum a-or b-carotene.
Apo E genotypes
Apo E genotype analyses were performed in all children and in 19 of the parents. Among the children, four Apo E genotype groups were identified, that is, Apo E2-3 (n ¼ 1), Apo E 3-3 (n ¼ 19), Apo E3-4 (n ¼ 16) and Apo E2-4 (n ¼ 1) genotype. The Apo E genotypes among the parents were: Apo E3-3 (n ¼ 10) and apo E3-4 (n ¼ 8) and Apo E2-4 (n ¼ 1). Baseline plasma cholesterol was similar in the Apo E3-3 (7.57 mmol/l) and Apo E3-4 groups (7.46 mmol/l) in the children and in the group of parents (Apo E3-3, 5.56 mmol/l; Apo E3-4, 5.90 mmol/l).
There was no significant difference in the response to the PSE spread between the Apo E3-3 and Apo E3-4 groups in plasma total or LDL cholesterol in the children during the controlled cross-over study (data not shown). The total and LDL cholesterol decreased by 8.2% (P ¼ 006) and 10.3% (P ¼ 0.003), respectively, in the Apo E3-3 group and by 8.3% (P ¼ 0.003) and 11.3% (P ¼ 0.001), respectively, in the Apo E3-4 group. The corresponding lipid reductions in the parents during the open-label period were 7.3% (ns) and 6.4% (ns) in the Apo E3-3 and 10.4% (P ¼ 0.033) and 10.9% (ns) in the apo E3-4 group, with no difference between the Apo E genotype groups.
There was no difference in the effect of PSE spread on serum lathosterol or plant sterol changes between the Apo E3-3 and Apo E3-4 groups in the children during the crossover study. Lathosterol, campesterol and sitosterol, adjusted to total cholesterol, increased by 44.2% (P ¼ 0.001), 96.1% (Po0.001) and 46.7% (Po0.001), respectively, in the Apo E3-3 group and by 17.4% (ns), 91.9% (Po0.001) and 45.9% (P ¼ 0.001), respectively, in the Apo E3-4 group.
Discussion
In the present study, the serum cholesterol-lowering effect of a PSE spread observed in a controlled cross-over period of 8 weeks in children with FH was maintained during an openlabel follow-up period of 26 weeks. The compliance of spread use was higher in the controlled period (91.7%) (Amundsen et al, 2002) , than in the open-label period (68.5%). The parents who were already on a steady dose of statins had an additional reduction in total and LDL-cholesterol levels. The serum lipid effects were not related to the apo E genotype in neither the children nor their parents. Serum concentration of plant sterols increased by two-fold in children but remained in the micromolar range.
We have demonstrated in this study that children and their parents can easily adapt a diet enriched with PSE to improve their plasma lipid profile and thus minimize the risk of atherosclerosis. The 6 months follow-up period, the first to be conducted in children with FH, did not show any side effects, changes in liver function, or any reported difficulties in complying to the diet. Surprisingly, HDL-cholesterol levels in both children and parents were lower at the end of the follow-up period. This is in contradiction to many published studies (Weststrate & Meijer 1998; Hendriks et al, 1999; Maki et al, 2001; Nestel et al, 2001; Geelen et al, 2002) . However, the total to HDL-cholesterol ratio was still improved with the PSE intake and no significant changes were seen in plasma TG. Since the open-label period was uncontrolled and took place during the summertime including a long holiday, the dietary intake may have been different from the preceding control period. Thus, the carbohydrate intake may have been higher in this period. We did not do a diet assessment during the open-label phase or included a control group, and these are limitations of the study. Furthermore, a decrease in total cholesterol and maybe HDL cholesterol may be a natural seasonal variation as lower serum cholesterol concentrations have been reported during the summertime (Robinson et al, 1992; Shahar et al, 1999) . Thus, we can not ignore that some of the lipid changes observed here might be due to this natural variation. In earlier papers, no effect of plant sterol ester-enriched spread intake on HDL cholesterol and TG has been reported in short-term and long-term studies (Weststrate & Meijer, 1998; Hendriks et al, 1999 Hendriks et al, , 2003 Nestel et al, 2001; Geelen et al, 2002) . However, if an HDL-cholesterol decrease would be a long-term consequence of plant sterol ester intake, it would be an undesirable effect.
Serum concentration of plant sterols increased in the children after intake of PSE-enriched spread during the controlled cross-over period. These increases were quite similar to those reported previously in adults ingesting PSE (Weststrate & Meijer, 1998; Jones et al, 2000; Hallikainen et al, 2000a) as well as in small children (Tammi et al, 2001 ). In the follow-up period, no further increase in campesterol was found, while for sitosterol a small increase was observed. One limitation of the present study is that the analyses of serum non-cholesterol sterols in the children were not performed at the same time for the cross-over and follow-up periods. There were, however, no differences between the analyzing methods or internal standards used at the two analyzing occasions.
Serum campesterol and sitosterol increased about 100 and 40% in the parents, respectively. In absolute terms, this means increases of about 1.95 mmol/mmol total cholesterol for campesterol and 0.91 mmol/mmol total cholesterol for sitosterol, which is considered a quite minor increase compared to the total serum sterol concentration. The long-term clinical implications of an increase in serum plant sterol concentration are unknown. It is, however, worth noting that the serum concentrations of campesterol and sitosterol observed both in the children and parents were still less than 8% of that observed in subjects with homozygous phytosterolemia (Lutjohann et al, 1996) . Furthermore, serum campesterol and sitosterol remained well below 1% of total serum sterols, while cholesterol accounts for more than 99% of serum sterols.
Serum lathosterol is found to correlate well with cholesterol synthesis (Bjorkhem et al, 1987; Miettinen et al, 1990) . The plasma cholesterol-adjusted lathosterol concentration increased by 35% in the children during the 8 weeks of PSE spread intake, and may thus indicate a similar increase in cholesterol synthesis. The further large increase of 259% in serum lathosterol measured after the PSE follow-up period was unexpected, but could indicate an upregulation of the cholesterol synthesis, which may have lead to minimizing any further reduction in plasma cholesterol concentration. The small and not significant increase of 5% in lathosterol levels in the parents may be explained by the intake of statins, which inhibit cholesterol synthesis. Similar findings were reported by (Gylling & Miettinen 2002) , where a low concentration of cholesterol precursors was reported after intake of plant stanol esters in subjects taking statins. It is also possible that the maximal effect of PSE is already reached after about 3 weeks and is then maintained at that level with no further decrease. A 1-y PSE intake study by Hendriks et al (2003) supports this. Thus, a subsequent increased cholesterol synthesis is not sufficient to compensate for the reduction of intestinal cholesterol absorption.
The increase in lipid-adjusted serum retinol concentrations observed in both the children and parents have, as far as we know, not been reported earlier after PSE intake. An increase in serum a-tocopherol was, however, also reported by Nestel et al (2001) . The retinol content of the control and PSE spread were very similar and could probably not explain the differences in serum levels. Other dietary changes could be a plausible explanation, but as presented earlier no difference in dietary intake was observed in the children between the two cross-over periods (Amundsen et al, 2002) . The intake of cod-liver oil containing both retinol and atocopherol could have been higher in the PSE-controlled period and PSE open-label period compared to the control period, although the subjects were instructed to take the same doses during all study periods. The content of atocopherol was somewhat higher with the intake of the PSE spread (10.6 mg/20 g spread) than the control spread (6.6 mg/20 g spread) and may explain some of the serum increase. Furthermore, seasonal variation in serum vitamin E has been reported and could be part of an explanation (Maes et al, 1996) . The decreases in a-and b-carotene in the PSE control period of 17.4 and 10.9%, respectively, were not recognized in our previous paper due to the use of other statistical methods. When including the start values in the statistical analyses, as in our previous paper, these decreases were not observed as statistically significant. For lycopene, however, a decrease of 8% disappeared when only end measurements were used. Both these statistical methods are widely used. The use of different statistical methods may therefore explain some of the variation in results reported about the effect of plant sterols on fat-soluble vitamins and carotenoids (Weststrate & Meijer 1998; Hendriks et al, 1999; Hallikainen et al, 2000a; Nestel et al, 2001; Maki et al, 2001) .
No dietary supplements containing carotenoids were used during the study. Although the dietary records in the controlled study did not show any difference in food intake during the intervention periods, one should keep in mind that a 4-days food record is too short to give valid data of the carotenoid intake. There was no decrease in serum carotenoids during the follow-up period either in the children or their parents. As this was during the summertime, the intake of fruits and vegetables may have been higher. Thus, both seasonal variation and changes in dietary intake may explain the variation in serum carotenoids found in the present follow-up study.
In several studies, the serum cholesterol-lowering effect of plant stanol esters has been shown to be larger in subjects with an Apo E4 than Apo E3 genoptype (Vanhanen et al, 1993; Miettinen & Vanhanen, 1994; Hallikainen et al, 2000a) . In at least two more recent studies, however, this was not confirmed (Hallikainen et al, 2000b; Plat & Mensink, 2000) . Two other studies (Hallikainen et al, 2000a; Geelen et al, 2002) , as well as the present study, do not support that there is a difference in serum lipid response to plant sterol esters between the Apo E3 and Apo E4 genotyes. Probably, the LDL-receptor mutations present in subjects with FH are much stronger determinants of the serum cholesterol concentration than the Apo E genotype.
To our knowledge, no previous study has studied the longterm compliance of a PSE spread in children with FH. Our results show that only about 69% of the recommended spread intake was consumed in the open-label period compared with 92% in the controlled period. There could be several explanations to the lower compliance in the openlabel period. This period included the summer holiday with changes in the usual dietary habits as well as travelling. Some parents also decided not to control the childrens' intake of spread during this period. On the other hand, about 50% of the parents also consumed the spread, and this could have been a motivation for their children. The 82% compliance in the parents shows, however, that some adults also may have difficulties in consuming 20 g of the PSE spread per day. Despite this, the plasma cholesterol decreased significantly in the parents as well. The additional effect of plant sterols or stanols to statin treatment has also been observed in postmenopausal women and coronary patients taking PSE or plant stanol ester-enriched spreads (Gylling et al, 1997; Gylling & Miettinen 2002; Simons, 2002) .
In conclusion, the present study has shown that plant sterols given as a PSE spread induced a significant plasma cholesterol-lowering effect in children with FH during a controlled diet period. This reduction was sustained during an open follow-up period of 6 months despite a 25% lower intake of spread. The effect seemed to be independent of the Apo E genotypes of the subjects. Significant lipid reductions were also observed in the FH parents given PSE spread on top of a daily intake of statins. Increases in serum retinol and atocopherol concentrations were observed in both children and parents. Serum carotenoids decreased in the children in the controlled study, while no changes were seen in children and parents during the open-label period. Increased intake of fruit and vegetables is recommended to compensate for possible decreases in serum carotenoids after intake of plant sterol ester-enriched spread.
